Novozymes OneHealth builds on parent company’s strategic vision

By Hank Schultz contact

- Last updated on GMT

Related tags: Enzymes, Probiotics, microbiome, Probiotic, Supplyside west

Novozymes, a long time player in industrial enzyme applications, has launched a consumer facing health division that becomes an instant heavy hitter in the category. The head of the division gave NutraIngredients-USA a peek behind the curtain.

Ulrich Irgens,  the head of the newly created Novozymes OneHealth, laid out the strategic vision for the relatively new division of the company in an interview at SupplySide West.

Irgens acknowledged the company’s background in health care, as its corporate DNA stretches back to parent company Novonordisk Pharma.  But now the company is looking at health from a wellness support perspective.

Vision had long gestation time

But that focus on consumer healthcare was a long time in gestation, he said.  Novozymes spun out of its parent company more than two decades ago, but it had a broad focus, with health care as only one aspect.

“It was really focused more on biotech, predominantly enzymes, but other types of biotech as well. It was really focused on industrial applications, home care, a bit of food and bev, ag, biofuel and so forth,​” Irgens said in an interview at the trade show in Las Vegas, NV.

“But about five years ago we realized there was a real need an opportunity to look toward health — not pharma, but in consumer healthcare and not just enzymes but looking at biology more broadly,”​ he said.

Building a brand

Novozymes had prepared for the launch of OneHealth with a series of strategic acquisitions.  Those included Precision Biotics, a practitioner channel probiotics manufacturer, in 2020 and Synergia Life Sciences, an Indian vitamin K2 manufacturer, in 2021.

The new division highlighted some ingredients at the show, including Pylopass Limosilactobacillus reuteri​ (formerly known as Lactobacillus reuteri​) DSM 17648, a postbiotic solution that may help to reduce the load of Helicobacter pylori​ in the stomach. H. pylori​ affects about half of the global population and the bacterium may cause gastric upset.

Also at the show, the company presented its probiotic solution for mental wellness called ProbioBrain Bifidobacterium longum​ 1714. The strain is supported by data from two placebo-controlled clinical trials, which showed an ability to help adults handle the psychological and physical responses to everyday stress, help reduce cortisol output in response to everyday stress, and help to maintain a calm state of mind and emotional balance.

Related news

Related products

show more

Winclove introduces Ecologic® AAD

Winclove introduces Ecologic® AAD

Winclove Probiotics | 12-Oct-2022 | Product Brochure

Ecologic® AAD has been tested in a randomized, double-blind, placebo-controlled trial with healthy volunteers taking amoxicillin, performed by Maastricht...

Innovative colic solutions

Innovative colic solutions

Recorded the 07-Jul-2022 | Webinar

Colic is one of the most frequent reasons for visits to the pediatrician and can often lead to parental and infant exhaustion. As a functional gastrointestinal...

Related suppliers

Follow us

Products

View more

Webinars